Boston Scientific To Acquire Interventional Radiology Business Of CeloNova Biosciences, Upfront Payment Of $70M Plus Additional Regulatory/Sales Milestone Payments

By: via Benzinga
Boston Scientific (NYSE: BSX) has entered into a definitive agreement to acquire the interventional radiology portfolio of CeloNova ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.